LETTERS TO THE EDITOR   Free access

Minerva Medica 2025 February;116(1):75-9

DOI: 10.23736/S0026-4806.22.08326-4

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

High-dose corticosteroids adjusted to oxygen requirement and monitoring of serum C-reactive protein to improve outcome of non-critically ill COVID-19 patients: the CocAA-CoLa Plus Study

Jean-Philippe KEVORKIAN ¹, Claire VANDIEDONCK ², Jean LAGANIER ³, Amanda LOPES ⁴, Ruxandra BURLACU ⁴, Florine FERON ¹, Marie-Laure CHAI X ⁵, Damien SENE ⁴, Jean-Pierre RIVELINE ¹, Jean-François GAUTIER ^{1, 2}, Bruno MEGARBANE ⁶ ✉

¹ Department of Diabetology and Endocrinology, Lariboisière Hospital, Paris Cité University, Paris, France; ² Paris Cité University, INSERM U1151, CNRS UMR8253, Necker Enfants-Malades Institute, Paris, France; ³ Department of Geriatrics, Lariboisière Hospital, Paris Cité University, Paris, France; ⁴ Department of Internal Medicine, Lariboisière Hospital, Paris Cité University, Paris, France; ⁵ Department of Virology, Saint-Louis Hospital, Paris Cité University, Paris, France; ⁶ Department of Medical and Toxicological Critical Care, Lariboisière Hospital, AP-HP Federation of Toxicology, Paris Cité University, INSERM UMRS-1144, Paris, France